Selle J G, Svenson R H, Gallagher J J, Sealy W C, Robicsek F
Sanger Clinic, Heineman Research Foundation, Charlotte, North Carolina.
Thorac Cardiovasc Surg. 1988 Jun;36 Suppl 2:155-8. doi: 10.1055/s-2007-1022993.
About 5-10% of patients after myocardial infarction experience sustained ventricular tachycardias. Drug therapy is successful only in 60% of these patients, so that a number of them is on a high risk of a sudden cardiac death. Indirect surgical approaches like myocardial revascularization, or aneurysm resection have proven to be ineffective in the treatment of these malignant tachycardias. By the development of electrophysiologic techniques a mechanism of the ventricular tachycardias could be identified as a micro-reentry at the border of myocardial infarction. On this base different direct surgical approaches were advocated by Guiraudon, proposing an encircling endocardial ventriculotomy and by Josephson and Harken recommending a subendocardial resection technique. The results of these direct procedures were much better than those of the prior indirect techniques. The mortality in this series was around 10% and there still was a postoperative recurrence of the tachycardia in about 20-30%. Our group started a study in which a Nd:YAG laser was used to photocoagulate areas of myocardium responsible for the initiation of ventricular tachycardia. By its deeper penetration depth the Nd:YAG laser was preferrable to other laser systems like CO2 and Argon-laser. In contrast to cryothermy the Nd:YAG showed three special advantages: First, it was more effective in the normothermic myocardium, it showed not peripheral zone of temporary myocardial injury, potentially causing late failures, and third equal ablation of tissue could be achieved in much shorter time. Patients were considered operative candidates when drug therapy failed. Preoperative investigations included formal cardiac catheterization and an electrophysiologic testing with induction and mapping of the ventricular tachycardia.(ABSTRACT TRUNCATED AT 250 WORDS)
约5% - 10%的心肌梗死后患者会出现持续性室性心动过速。药物治疗仅在60%的此类患者中取得成功,因此其中一些人面临心脏性猝死的高风险。诸如心肌血运重建或动脉瘤切除等间接手术方法已被证明在治疗这些恶性心动过速方面无效。随着电生理技术的发展,室性心动过速的机制可被确定为心肌梗死边界处的微折返。在此基础上,吉劳东倡导了不同的直接手术方法,提出环绕心内膜心室切开术,约瑟夫森和哈肯则推荐心内膜下切除术。这些直接手术的结果比之前的间接技术要好得多。该系列的死亡率约为10%,术后仍有大约20% - 30%的心动过速复发。我们小组开展了一项研究,使用钕钇铝石榴石激光对引发室性心动过速的心肌区域进行光凝。由于其更深的穿透深度,钕钇铝石榴石激光比二氧化碳和氩激光等其他激光系统更具优势。与冷冻疗法相比,钕钇铝石榴石激光具有三个特殊优势:第一,它在常温心肌中更有效;第二,它没有可能导致晚期失败的临时心肌损伤周边区域;第三,在更短的时间内可以实现同等程度的组织消融。当药物治疗失败时,患者被视为手术候选者。术前检查包括正式的心导管检查以及室性心动过速的诱发和标测的电生理测试。(摘要截短于250字)